Visual analysis of the economic burden of tuberculosis patients based on CiteSpace

doi:10.19982/j.issn.1000-6621.20260049

Abstract

Abstract:

Objective: To analyze the hotspots and trends of research on the economic burden of tuberculosis patients at home and abroad from 2010 to 2025, and to provide reference for research in this field. Methods: Relevant Chinese and English literatures published from January 1, 2010 to December 31, 2025 in CNKI, Wanfang, VIP, SinoMed, Web of Science and PubMed databases were retrieved. CiteSpace software was used to visualize the number of publications, countries (regions), authors, institutions and keywords. Results: A total of 623 Chinese articles and 1891 English articles were included. The annual number of Chinese and English articles increased from 30 and 57 in 2010 to 48 and 142 in 2025, respectively. The top five countries in terms of total number of publications were the United States (517 papers), the United Kingdom (172 papers), South Africa (116 papers), China (107 papers) and India (78 papers). The network analysis of authors and institutions showed that the high-yield authors in China were Wang Lixia (20 papers), Zhang Hui (14 papers), Li Renzhong (12 papers) and so on. The National Center for Tuberculosis Control and Prevention, Chinese Center for Disease Control and Prevention occupied a central position in the Chinese literature, with 31 publications. The foreign high-yield authors were Anna Vassall (24 papers), Knut L?nnroth (20 papers), Robert G·White (18 papers) and so on. The University of London occupied a core position in English-language literature, with 101 publications. Keyword analysis showed that Chinese literature focused on patients and policy issues such as “multidrug-resistant tuberculosis” and “medical insurance”, while English literature focused more on systematic and evaluation methods such as “cost-effectiveness analysis” “catastrophic expenditures” and “health expenditure”. Conclusion: The number of Chinese and English publications is on the rise from 2010 to 2025. The research perspective on the economic burden of tuberculosis patients in the world is becoming more and more comprehensive, from single cost measurement to multi-dimensional assessment of economy, health and policy. In the future, we should strengthen interdisciplinary cooperation, focus on vulnerable groups and promote the transformation of research into policy.

Key words: Tuberculosis, Economics, medical, Bibliometrics

CLC Number:

Man Yi, Wu Yanlong, Li Shuanglin, Li Xinyi, Pei Qiongyun, Niu Lingpu, Wu Tengyan. Visual analysis of the economic burden of tuberculosis patients based on CiteSpace[J]. Chinese Journal of Antituberculosis, 2026, 48(10): 1627-1634. doi: 10.19982/j.issn.1000-6621.20260049

Figures/Tables 7

References 21

[1]	屈燕, 李涛, 马文斌, 等. 世界卫生组织《2025年全球结核病报告》解读[J]. 结核与肺部疾病杂志, 2025, 6(6): 613-623. doi:10.19983/j.issn.2096-8493.20250178.
[2]	全国第五次结核病流行病学抽样调查技术指导组, 全国第五次结核病流行病学抽样调查办公室. 2010年全国第五次结核病流行病学抽样调查报告[J]. 中国防痨杂志, 2012, 34(8): 485-508.
[3]	吴波, 刘英, 廖文平, 等. 重庆市四区县肺结核患者经济负担分析[J]. 中国防痨杂志, 2022, 44(4): 390-396. doi:10.19982/j.issn.1000-6621.20210633.
[4]	徐飚. 规范结核病诊疗服务实现零家庭灾难性卫生支出[J]. 中国防痨杂志, 2019, 41(5):485-487. doi:10.3969/j.issn.1000-6621.2019.05.004.
[5]	Shete P B, Reid M, Goosby E. Message to world leaders: we cannot end tuberculosis without addressing the social and economic burden of the disease[J]. Lancet Glob Health, 2018, 6(12): e1272-e1273. doi:10.1016/S2214-109X(18)30378-4. pmid: 30224288
[6]	Pedrazzoli D, Borghi J, Viney K, et al. Measuring the economic burden for TB patients in the End TB Strategy and Universal Health Coverage frameworks[J]. Int J Tuberc Lung Dis, 2019, 23(1): 5-11. doi:10.5588/ijtld.18.0318. pmid: 30674374
[7]	Xu C, Xia Y, Hu D, et al. Financial Burden of Tuberculosis Patients—China, 2020[J]. China CDC Wkly, 2023, 5(12): 266-270. doi:10.46234/ccdcw2023.048.
[8]	陈瑶, 曾雪扬, 杨丰文, 等. 基于CiteSpace的中医药领域网状Meta分析的研究热点可视化分析[J]. 中国中药杂志, 2020, 45(18): 4500-4509. doi:10.19540/j.cnki.cjcmm.20200324.501.
[9]	陈洪锋, 唐叶丹, 黄湾, 等. 嵌合抗原受体T细胞疗法护理相关热点的可视化分析[J]. 护理学杂志, 2025, 40(18): 32-37. doi:10.3870/j.issn.1001-4152.2025.18.032.
[10]	World Health Organization. Global tuberculosis report 2021[R]. Geneva: World Health Organization, 2021.
[11]	McQuaid C F, McCreesh N, Read J M, et al. The potential impact of COVID-19-related disruption on tuberculosis burden[J]. Eur Respir J, 2020, 56(2): 2001718. doi:10.1183/13993003.01718-2020.
[12]	Cilloni L, Fu H, Vesga J F, et al. The potential impact of the COVID-19 pandemic on the tuberculosis epidemic a modelling analysis[J]. EClinicalMedicine, 2020, 28: 100603. doi:10.1016/j.eclinm.2020.100603.
[13]	Silva S, Arinaminpathy N, Atun R, et al. Economic impact of tuberculosis mortality in 120 countries and the cost of not achieving the Sustainable Development Goals tuberculosis targets: a full-income analysis[J]. Lancet Glob Health, 2021, 9(10): e1372-e1379. doi:10.1016/S2214-109X(21)00299-0. pmid: 34487685
[14]	常煜博, 贺顺, 王侠, 等. 基于疾病特征的医保支付方式优化策略研究——以结核病为例[J]. 卫生经济研究, 2024, 41(6): 31-33, 38.
[15]	刘方珉, 吴春峰, 吴国柱, 等. 上海市耐多药结核病患者经济负担研究[J]. 中国卫生资源, 2023, 26(1): 42-49. doi:10.3969/j.issn.1007-953X.2023.01.008.
[16]	杨逸轩, 辛继宾, 阮巧玲, 等. 文献计量视角下的结核分枝杆菌潜伏感染研究现状与展望[J]. 中国防痨杂志, 2024, 46(10): 1209-1218. doi:10.19982/j.issn.1000-6621.20240235.
[17]	田晓梅, 何小雪, 雷娟, 等. 2019—2023年宁夏回族自治区病原学阳性肺结核治疗效果及影响因素分析[J]. 结核与肺部疾病杂志, 2025, 6(6): 703-709. doi:10.19983/j.issn.2096-8493.20250084.
[18]	Portnoy A, Yamanaka T, Nguhiu P, et al. Costs incurred by people receiving tuberculosis treatment in low-income and middle-income countries: a meta-regression analysis[J]. Lancet Glob Health, 2023, 11(10): e1640-e1647. doi:10.1016/S2214-109X(23)00369-8. pmid: 37734806
[19]	刘海灿. 结核病监测专题[J]. 疾病监测, 2025, 40(8): 965.
[20]	赵永年, 张丽杰, 王童敏. 2014—2023年新疆生产建设兵团肺结核报告发病流行病学特征分析[J]. 结核与肺部疾病杂志, 2025, 6(1):30-34. doi:10.19983/j.issn.2096-8493.2024165.
[21]	周璇, 黄琇棠, 唐东锋, 等. 我国门诊医保支付方式对比研究[J]. 卫生经济研究, 2022, 39(11): 19-22.

序号	发文量(篇)	中介中心性	国家
1	517	0.29	美国
2	172	0.26	英国
3	116	0.08	南非
4	107	0.04	中国
5	78	0.10	印度
6	73	0.19	瑞士
7	54	0.06	瑞典
8	48	0.05	荷兰
9	46	0.08	澳大利亚
10	34	0.04	加拿大